Phreesia (NYSE:PHR) Reaches New 52-Week High - Still a Buy?

Phreesia, Inc. (NYSE:PHR - Get Free Report)'s stock price hit a new 52-week high on Wednesday . The stock traded as high as $29.36 and last traded at $29.25, with a volume of 641745 shares changing hands. The stock had previously closed at $26.98.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. Robert W. Baird dropped their target price on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a research report on Wednesday, December 11th. Truist Financial boosted their target price on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. JMP Securities reissued a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. KeyCorp boosted their price objective on Phreesia from $28.00 to $30.00 and gave the stock an "overweight" rating in a report on Wednesday, January 8th. Finally, Royal Bank of Canada upgraded Phreesia from a "sector perform" rating to an "outperform" rating and raised their price target for the stock from $24.00 to $32.00 in a research report on Wednesday, January 8th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Buy" and an average price target of $31.15.

Phreesia Trading Down 1.8 %

The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $1.65 billion, a P/E ratio of -19.37 and a beta of 0.94. The business has a fifty day moving average price of $24.98 and a 200 day moving average price of $23.28.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts' consensus estimates of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The firm had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter in the prior year, the firm posted ($0.58) EPS. The business's revenue was up 16.6% on a year-over-year basis. On average, analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Activity at Phreesia

In related news, COO Evan Roberts sold 2,681 shares of the business's stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $27.95, for a total transaction of $74,933.95. Following the transaction, the chief operating officer now directly owns 769,993 shares in the company, valued at approximately $21,521,304.35. The trade was a 0.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Amy Beth Vanduyn sold 25,447 shares of the company's stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $20.93, for a total transaction of $532,605.71. Following the sale, the senior vice president now directly owns 93,470 shares in the company, valued at $1,956,327.10. This trade represents a 21.40 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 166,153 shares of company stock valued at $4,191,304. Corporate insiders own 5.80% of the company's stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds and other institutional investors have recently bought and sold shares of PHR. Champlain Investment Partners LLC boosted its stake in shares of Phreesia by 4.1% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after acquiring an additional 97,847 shares during the period. Sei Investments Co. boosted its position in Phreesia by 135.3% during the second quarter. Sei Investments Co. now owns 165,327 shares of the company's stock worth $3,505,000 after purchasing an additional 95,058 shares during the period. State Street Corp increased its holdings in shares of Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company's stock valued at $30,256,000 after purchasing an additional 88,517 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Phreesia by 4.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock worth $28,397,000 after buying an additional 55,934 shares during the last quarter. Finally, Barclays PLC boosted its holdings in shares of Phreesia by 83.6% during the 3rd quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after buying an additional 43,225 shares during the period. Institutional investors own 92.10% of the company's stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.